Skip To Main Content
Abraham Dessie Gessesse on Muck Rack

Abraham Dessie Gessesse

As seen in: Nature, PLOS ONE
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Abraham Dessie

Contact Abraham Dessie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Adherence, effectiveness, safety, and predictors of treatment outcomes among children and adolescents receiving dolutegravir based antiretroviral therapy in Ethiopia

|
By Yabibal Asfaw Derso, Tadesse Misganaw, Abraham Dessie Gessesse, Dagnew Tigabu, Fikadie Dagnew Baye, Lemlem Ewunetu
| Nature Verified
Abstract The World Health Organization advised integrase inhibitor dolutegravir as the first- and second-line treatment of choice for Human Immunodeficiency Virus in July 2019 for all populations. Since 2019, the Ministry of Health in Ethiopia has recommended that adults, adolescents, and pregnant women adopt it as their first-line regimen for antiretroviral therapy.
Open in Who Shared Issue with article?

A systematic review and meta-analysis on the epidemiology of work-related musculoskeletal disorders among nurses in Ethiopia

|
By Abel Desalegn Demeke, Abraham Dessie Gessesse, Etaferaw Bekele Auddo
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Demeke AD, Gessesse AD, Auddo EB, Tamir T, Bayable A, Demeke A (2026) A systematic review and meta-analysis on the epidemiology of work-related musculoskeletal disorders among nurses in Ethiopia. PLoS One 21(7): e0354484.
Open in Who Shared Issue with article?

The rising burden of female cancer in Ethiopia (2000-2021) and projections to 2040: Insights from the global burden of disease study

|
By Tesfaye Engdaw Habtie, Tegene Atamenta Kitaw, Molalign Aligaz Adisu, Abraham Dessie Gessesse
| PLOS ONE
Citation: Adisu MA, Habtie TE, Kitaw TA, Gessesse AD, Woreta BM, Derso YA, et al. (2025) The rising burden of female cancer in Ethiopia (2000–2021) and projections to 2040: Insights from the global burden of disease study. PLoS One 20(10): e0333787. https://doi.org/10.1371/journal.pone.0333787 Editor: Thien Tan Tri Tai Truyen, Cedars-Sinai Heart Institute, UNITED STATES OF AMERICA Received: July 1, 2025; Accepted: September 18, 2025; Published: October 7, 2025 Copyright: © 2025 Adisu et al.
Open in Who Shared Issue with article?
See all 3 articles